Ramiro Ribeiro After six years as head of clinical development at Apellis Pharmaceuticals, Ramiro Ribeiro is joining EyePoint Pharmaceuticals as...
Baptism by Fire
Panic Deepens, US Employment Data Means Little
Near-Term Price Action in the Context of the Larger Dollar Cycle
Now We are Getting Serious
Welcome to the High Vol World: What the Charts Say
Monday Blues: Fed Moves Bigly and Stocks Slump
ECB's Bazooka Support Bonds but not the Euro
High Anxiety is Auto-Correlated
The Economic Tsunami that has Begun and the Drive for Cash
Relief Bounce On Tuesday, but Turn Around not Secure
10 Sunday Reads
Primer: The Trillion Dollar Coin
Ending Lockdown?
New Highs Tilt Scales to Bulls
Bad Case of Deja Vu – Another 3% S&P 500 Decline